Lower-cost biotech drug gets thumbs up from FDA panel
Wednesday, July 13, 2016 - 15:47
in Health & Medicine
WASHINGTON (AP) -- The second-biggest selling drug in the world could get some cheaper competition in the U.S., after a federal panel endorsed an alternative version of the pricey medication used to treat rheumatoid arthritis and other inflammatory diseases....